[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
ARWR
Arrowhead Pharmaceuticals to receive $100M milestone payment from Sarepta. Sarepta reaffirms partnership amid public scrutiny.
About ARWR
ARWR is the stock ticker for Arrowhead Pharmaceuticals, a biotechnology company.
Engagements: XXXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Month: XXXXXX -XX%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX -XXXX%
1-Year High: XXXXXXX on 2024-11-26
1-Year Low: X on 2025-06-15
| Social Network | X | YouTube | News | |
|---|---|---|---|---|
| Engagements | XXXXXX | X | X | X |
Mentions: XXX #
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
6 Months: XXXXX -XX%
1 Year: XXXXX +157%
1-Year High: XXX on 2024-11-29
1-Year Low: X on 2025-06-14
| Social Network | X | YouTube | News | |
|---|---|---|---|---|
| Mentions | XXX | X | XX | X |
Creators: XXX #
Creators 24-Hour Chart Data
XXX unique social accounts have posts mentioning ARWR in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
6 Months: XXX -XX%
1 Year: XXXXX +118%
1-Year High: XXX on 2024-11-29
1-Year Low: X on 2025-06-14
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-07-29
1-Year Low: XX% on 2025-03-20
Most Supportive Themes
- Milestone Payment from Sarepta: (60%) Arrowhead Pharmaceuticals is expected to receive a $XXX million milestone payment from Sarepta Therapeutics, with the potential for an additional $XXX million.
- Arrowhead's Statement: (25%) Arrowhead's statement on the ongoing agreement with Sarepta, reaffirming their commitment.
Most Critical Themes
- Sarepta Partnership Concerns: (15%) Concerns about Sarepta's financial stability and its potential impact on the Arrowhead partnership are being discussed.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXXX | XX% | XXX | X% |
| YouTube | X | X% | X | X% | X | X% |
| X | X% | X | X% | X | X% | |
| News | X | X% | X | X% | X | X% |
| Total | XXXXX | XX% | XXXXXX | XX% | XXX | X% |
Top assets mentioned In the posts about ARWR in the last XX hours
Arrowhead Research Corporation (ARWR) Sarepta Therapeutics, Inc. (SRPT) Sarepta Therapeutics, Inc. (SRPT) Regeneron Pharmaceuticals Inc (REGN) Bitcoin Incognito (XBI) SuperRare (RARE) Alnylam Pharmaceuticals, Inc. (ALNY) Hundred Million (100M) Avidity Biosciences, Inc. Common Stock (RNA) Akropolis (AKRO)
Top topics mentioned In the posts about ARWR in the last XX hours
$srpt, stocks healthcare, sarepta therapeutics inc, $adpt, $bcrx, $regn, $nktr, stocks, sarepta therapeutics, investment, arrowhead, nvda, $wve, $xbi, $rgnx, amzn, 100m, $rare, $qure, coins ai, pltr, $alny, $100m, chapter 11, money, btc eth, qqq, akro, $ibb, $crbu, $cmps, $200m, pika, mstr, googl, cvx, spx, drugs, vrtx, nasdaq, qbts, stx, $300m, $prme, $rna, $mor, $qntm, $akro, msft, momentum, rating agency, nke, $sgmo, $vrtx, $verv, ip, $tnxp, smr, $srpttype, uptrend, spy, files, dip, hood, debt, balance sheet, $hnsa, $morf, aal, lode, $moh, $amgn, pgen, cnc, $brkr, alnylam pharmaceuticals inc, amgn, $psnl, smci, billions, $prqr, $allo, $grph, $otlk, $vnda, $50m, $325m, coins healthcare, cns, acquisition, underway, alt, $1b, $argx, $sana, $tsla, prob, $cura, regeneron pharmaceuticals inc, $incy
Top News #
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"Arrowhead Pharmaceuticals Issues Statement on the Status of its Ongoing Agreement with Sarepta Therapeutics"
@YahooFinance on X 2025-07-23 19:50:44 UTC 208.1M followers, XXX engagements
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Arrowhead to receive $100M milestone payment from Sarepta via Triggered by enrollment milestone in ARO-DM1 trial (type X myotonic dystrophy) Additional $200M possible by end of 2025 Sarepta reaffirms partnership amid public scrutiny $SRPT +12% $ARWR +3.7%"
@overnight_stock on X 2025-07-28 16:28:24 UTC XXX followers, XXX engagements
"$SRPT +12% $ARWR +3.7% Arrowhead announced it expects to receive $100M in milestone payments from Sarepta within XX days after reaching the first enrollment target in a clinical study of ARO-DM1 for type X myotonic dystrophy. A second target by the end of 2025 could trigger an additional $200M payment. Sarepta affirmed its commitment to Arrowhead amid public pressure"
@notreload_ai on X 2025-07-28 16:23:49 UTC 2620 followers, XXX engagements
"Just in: Arrowhead $ARWR to receive $100M from Sarepta $SRPT after hitting a milestone in its ARO-DM1 study. Sarepta confirms commitment to payments amid pressure from Arrowhead. Arrowhead shares up X% Sarepta up 9%. (Source: Bloomberg)"
@TipRanks on X 2025-07-28 16:20:16 UTC 33.7K followers, 1246 engagements
"$SRPT $ARWR: $100M milestone for siRNA dev should be viewed as quite a good asset isn't it Now it must be darkest time for $SRPT. Nothing is viewed as positive. Not even steady revenues from RNA splicing drugs for DMD I would say time to be long $SRPT. Added some avg XX now"
@pick1998_2 on X 2025-07-28 16:03:49 UTC 6951 followers, 3025 engagements